Anticancer Role of PPARγ Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes

Anticancer Role of PPARγ Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes

The use of targeted cancer therapies in combination with conventional chemotherapeutic agents and/or radiation treatment has increased overall survival of cancer patients. However, longer survival is accompanied by increased incidence of comorbidities due, in part, to drug side effects and toxiciti...

Full description

Saved in:

Bibliographic Details
Main Authors:	P. J. Simpson-Haidaris, S. J. Pollock, S. Ramon, N. Guo, C. F. Woeller, S. E. Feldon, R. P. Phipps
Format:	Article
Language:	English
Published:	Wiley 2010-01-01
Series:	PPAR Research
Online Access:	http://dx.doi.org/10.1155/2010/814609
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
by: Ajit A. Kulkarni, et al.
Published: (2012-01-01)

The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists
by: Tamotsu Tsukahara
Published: (2012-01-01)

PPARγ and Its Agonists in Chronic Kidney Disease
by: Yuhua Ma, et al.
Published: (2020-01-01)

PPAR-γ Agonists and Their Role in Primary Cicatricial Alopecia
by: Sarawin Harnchoowong, et al.
Published: (2017-01-01)

Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonist
by: Jarosz-Biej Magdalena, et al.
Published: (2025-02-01)

Combined Effects of PPARγ Agonists and Epidermal Growth Factor Receptor Inhibitors in Human Proximal Tubule Cells
by: Katherine Pegg, et al.
Published: (2013-01-01)

New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
by: Zhanjun Jia, et al.
Published: (2014-01-01)

The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria
by: Lena Serghides
Published: (2012-01-01)

Regulation of Glial Cell Functions by PPAR-𝜸 Natural and Synthetic Agonists
by: Antonietta Bernardo, et al.
Published: (2008-01-01)

PPAR-γ Agonists and Their Effects on IGF-I Receptor Signaling: Implications for Cancer
by: A. Belfiore, et al.
Published: (2009-01-01)

PPARγ and the Innate Immune System Mediate the Resolution of Inflammation
by: Amanda Croasdell, et al.
Published: (2015-01-01)

Combination PPARγ and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2
by: Joshua P. Klopper, et al.
Published: (2010-01-01)

Protective Effect of PPARγ Agonists on Cerebellar Tissues Oxidative Damage in Hypothyroid Rats
by: Yousef Baghcheghi, et al.
Published: (2016-01-01)

Role of Peroxisome Proliferator-Activated Receptor Gamma and Its Ligands in the Treatment of Hematological Malignancies
by: Richard P. Phipps, et al.
Published: (2008-01-01)

The PPARγ Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects
by: Galina S. Bogatkevich, et al.
Published: (2012-01-01)

PPAR Agonists for the Prevention and Treatment of Lung Cancer
by: Sowmya P. Lakshmi, et al.
Published: (2017-01-01)

PPAR Agonists and Cardiovascular Disease in Diabetes
by: Anna C. Calkin, et al.
Published: (2008-01-01)

PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists
by: Neerupma Silswal, et al.
Published: (2012-01-01)

Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats
by: Sheryar Afzal, et al.
Published: (2021-01-01)

PPARγ Agonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice
by: Ying Sun, et al.
Published: (2013-01-01)

Targeting TCMR-associated cytokine genes for drug screening identifies PPARγ agonists as novel immunomodulatory agents in transplantation
by: Lu Hu, et al.
Published: (2025-01-01)

Global Gene Expression Profiling in PPAR-γ Agonist-Treated Kidneys in an Orthologous Rat Model of Human Autosomal Recessive Polycystic Kidney Disease
by: Daisuke Yoshihara, et al.
Published: (2012-01-01)

Mechanisms Mediating the Effects of γ-Tocotrienol When Used in Combination with PPARγ Agonists or Antagonists on MCF-7 and MDA-MB-231 Breast Cancer Cells
by: Abhita Malaviya, et al.
Published: (2013-01-01)

Resolving the Two “Bony” Faces of PPAR-γ
by: Beata Lecka-Czernik, et al.
Published: (2006-01-01)

The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells
by: Adrienne Bolden, et al.
Published: (2012-01-01)

AMPK-Dependent Metabolic Regulation by PPAR Agonists
by: Woo Hyung Lee, et al.
Published: (2010-01-01)

Cannabinoids: A New Group of Agonists of PPARs
by: Yan Sun, et al.
Published: (2007-01-01)

Inhibitory Effects of a Novel PPAR-γ Agonist MEKT1 on Pomc Expression/ACTH Secretion in AtT20 Cells
by: Rehana Parvin, et al.
Published: (2018-01-01)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
by: Robert I. Glazer, et al.
Published: (2008-01-01)

PPAR-γ Signaling Crosstalk in Mesenchymal Stem Cells
by: Ichiro Takada, et al.
Published: (2010-01-01)

PPARγ in Bacterial Infections: A Friend or Foe?
by: Aravind T. Reddy, et al.
Published: (2016-01-01)

Identification of Bexarotene as a PPARγ Antagonist with HDX
by: David P. Marciano, et al.
Published: (2015-01-01)

PPARγ in Inflammatory Bowel Disease
by: Vito Annese, et al.
Published: (2012-01-01)

Role of PPARα and Its Agonist in Renal Diseases
by: Ching-Feng Cheng, et al.
Published: (2010-01-01)

Therapeutic Implications of PPARγ in Human Osteosarcoma
by: Eric R. Wagner, et al.
Published: (2010-01-01)

PPARγ as a Novel Therapeutic Target in Lung Cancer
by: Aravind T. Reddy, et al.
Published: (2016-01-01)

Review of the Structural and Dynamic Mechanisms of PPARγ Partial Agonism
by: Alice J. Kroker, et al.
Published: (2015-01-01)

PPARγ and Its Role in Cardiovascular Diseases
by: Mini Chandra, et al.
Published: (2017-01-01)

Therapeutic Implications of PPARγ in Cardiovascular Diseases
by: Hiroshi Hasegawa, et al.
Published: (2010-01-01)

Thiazolidinediones on PPARγ: The Roles in Bone Remodeling
by: Wei Wei, et al.
Published: (2011-01-01)